HBV

Qiang Gao1, Hongwen Zhu2, Liangqing Dong1

  • 1Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, 180 Fenglin Road, Shanghai 200032, China.

Cell
|October 5, 2019
PubMed
概括

本研究为首次对与乙型肝炎病毒 (HBV) 相关的肝癌 (HCC) 进行蛋白基因分析. 它确定了不同的患者子组和生物标志物,提供了有关疾病机制和潜在治疗方法的见解.